These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35216595)

  • 21. Effect of Preoperative Tricuspid and/or Mitral Regurgitation on Development of Late Right-Sided Heart Failure After Insertion of the HeartWare Left Ventricular Assist Device.
    Gonzalez-Fernandez O; Bouzas-Cruz N; Ferrera C; Woods A; Robinson-Smith N; Tovey S; Parry G; MacGowan GA; Schueler S
    Am J Cardiol; 2020 Jan; 125(2):236-243. PubMed ID: 31767121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent mitral regurgitation after left ventricular assist device: a clinical conundrum.
    Cruz Rodriguez JB; Chatterjee A; Pamboukian SV; Tallaj JA; Joly J; Lenneman A; Aryal S; Hoopes CW; Acharya D; Rajapreyar I
    ESC Heart Fail; 2021 Apr; 8(2):1039-1046. PubMed ID: 33471962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of preoperative mitral regurgitation on left ventricular assist device patients: propensity score-matched analysis of the EUROMACS dataset.
    Loforte A; Nersesian G; Lewin D; Lanmueller P; Gliozzi G; Stein J; Cavalli GG; Schoenrath F; Netuka I; Zimpfer D; de By TMMH; Gummert J; Falk V; Meyns B; Faerber G; Pacini D; Potapov E
    Eur J Cardiothorac Surg; 2023 Feb; 63(2):. PubMed ID: 36637204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience.
    Taramasso M; Denti P; Buzzatti N; De Bonis M; La Canna G; Colombo A; Alfieri O; Maisano F
    Eur J Cardiothorac Surg; 2012 Dec; 42(6):920-6. PubMed ID: 22961958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of mitral valve intervention with left ventricular assist device implantation on postoperative outcomes and morphologic change.
    Hata H; Fujita T; Ishibashi-Ueda H; Kuroda K; Seguchi O; Matsumoto Y; Yanase M; Sato T; Nakajima S; Fukushima N; Kobayashi J
    J Artif Organs; 2018 Jun; 21(2):164-171. PubMed ID: 29181740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resolution of Mitral Regurgitation With Left Ventricular Assist Device Support.
    Goodwin M; Nemeh HW; Borgi J; Paone G; Morgan JA
    Ann Thorac Surg; 2017 Sep; 104(3):811-818. PubMed ID: 28527962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left ventricular assist device implantation and concomitant mitral valve surgery: A systematic review and meta-analysis.
    Arjomandi Rad A; Fleet B; Zubarevich A; Nanchahal S; Naruka V; Subbiah Ponniah H; Vardanyan R; Sardari Nia P; Loubani M; Moorjani N; Schmack B; Punjabi PP; Schmitto J; Ruhparwar A; Weymann A
    Artif Organs; 2024 Jan; 48(1):16-27. PubMed ID: 37822301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversibility of severe mitral valve regurgitation after left ventricular assist device implantation: single-centre observations from a real-life population of patients.
    Dobrovie M; Spampinato RA; Efimova E; da Rocha E Silva JG; Fischer J; Kuehl M; Voigt JU; Belmans A; Ciarka A; Bonamigo Thome F; Schloma V; Dmitrieva Y; Lehmann S; Hahn J; Strotdrees E; Mohr FW; Garbade J; Meyer AL
    Eur J Cardiothorac Surg; 2018 Jun; 53(6):1144-1150. PubMed ID: 29351635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of right heart function on outcome in patients with functional mitral regurgitation and chronic heart failure undergoing percutaneous edge-to-edge-repair.
    Osteresch R; Diehl K; Kühl M; Fiehn E; Schmucker J; Backhaus T; Fach A; Wienbergen H; Hambrecht R
    J Interv Cardiol; 2018 Dec; 31(6):916-924. PubMed ID: 30397932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural history and predictors of outcome in patients with concomitant functional mitral regurgitation at the time of aortic valve replacement.
    Ruel M; Kapila V; Price J; Kulik A; Burwash IG; Mesana TG
    Circulation; 2006 Jul; 114(1 Suppl):I541-6. PubMed ID: 16820634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subannular repair for functional mitral regurgitation type IIIb in patients with ischaemic versus dilated cardiomyopathy.
    Pausch J; Sequeira Gross T; Müller L; von Stumm M; Kloth B; Reichenspurner H; Girdauskas E
    Eur J Cardiothorac Surg; 2021 Jul; 60(1):122-130. PubMed ID: 33693797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MitraClip implantation followed by insertion of a left ventricular assist device in patients with advanced heart failure.
    Kreusser MM; Hamed S; Weber A; Schmack B; Volz MJ; Geis NA; Grossekettler L; Pleger ST; Ruhparwar A; Katus HA; Raake PW
    ESC Heart Fail; 2020 Dec; 7(6):3891-3900. PubMed ID: 33107214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cluster analysis of preoperative echocardiographic findings and outcomes following left ventricular device implantation.
    Tang PC; Haft JW; Romano MA; Bitar A; Hasan R; Palardy M; Wu X; Aaronson K; Pagani FD
    J Thorac Cardiovasc Surg; 2019 May; 157(5):1851-1860.e1. PubMed ID: 30739772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of functional mitral regurgitation recurrence after percutaneous mitral valve repair.
    Hellhammer K; Haurand JM; Spieker M; Luedike P; Rassaf T; Zeus T; Kelm M; Westenfeld R; Horn P
    Heart Vessels; 2021 Oct; 36(10):1574-1583. PubMed ID: 33811553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concomitant mitral valve procedures in patients undergoing implantation of continuous-flow left ventricular assist devices: An INTERMACS database analysis.
    Robertson JO; Naftel DC; Myers SL; Tedford RJ; Joseph SM; Kirklin JK; Silvestry SC
    J Heart Lung Transplant; 2018 Jan; 37(1):79-88. PubMed ID: 29150326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolution of Functional Mitral Regurgitation and Prognosis in Medically Managed Heart Failure Patients With Reduced Ejection Fraction.
    Nasser R; Van Assche L; Vorlat A; Vermeulen T; Van Craenenbroeck E; Conraads V; Van der Meiren V; Shivalkar B; Van Herck P; Claeys MJ
    JACC Heart Fail; 2017 Sep; 5(9):652-659. PubMed ID: 28859754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Echocardiographic findings in stable outpatients with properly functioning HeartMate II left ventricular assist devices.
    Topilsky Y; Oh JK; Atchison FW; Shah DK; Bichara VM; Schirger JA; Kushwaha SS; Pereira NL; Park SJ
    J Am Soc Echocardiogr; 2011 Feb; 24(2):157-69. PubMed ID: 21281909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of outcome in heart failure patients with severe functional mitral regurgitation undergoing MitraClip treatment.
    Baldi C; Citro R; Silverio A; Di Maio M; De Rosa R; Bonadies D; Verolino G; Esposito L; Mastrogiovanni G; Di Muro MR; Piscione F; Galasso G
    Int J Cardiol; 2019 Jun; 284():50-58. PubMed ID: 30360995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fate of preoperative moderate mitral regurgitation following left ventricular assist device implantation.
    Tang PC; Duggal NM; Haft JW; Aaronson KD; Pagani FD
    J Card Surg; 2021 Jun; 36(6):1843-1849. PubMed ID: 33604994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Right ventricular evaluation to improve survival outcome in patients with severe functional mitral regurgitation and advanced heart failure undergoing MitraClip therapy.
    Giannini C; Fiorelli F; Colombo A; De Carlo M; Weisz SH; Agricola E; Godino C; Castriota F; Golino P; Petronio AS
    Int J Cardiol; 2016 Nov; 223():574-580. PubMed ID: 27561163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.